ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
97,639.90
-0.58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Aurinia Pharmaceuticals Inc (0UJF) Cotización

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (0UJF)

LSE
7.80
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
7.80
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
170
0.00 Rango del Día 0.00
7.80 Rango de 52 semanas 7.80
Capitalización de Mercado [m]
1.122B
Precio Anterior
7.80
Precio de Apertura
-
Hora
170
@
697.99
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
187
Acciones en circulación
143,833,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-15.74
Beneficio por acción (BPA)
-0.54
turnover
175.51M
Beneficio neto
-78.02M

Acerca de Aurinia Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.auriniapharma.com
Sede
Victoria, British Columbia, Can
Fundado
-
Aurinia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0UJF. The last closing price for Aurinia Pharmaceuticals was $7.80. Over the last year, Aurinia Pharmaceuticals shares have traded in a share price range of $ 7.80 to $ 7.80.

Aurinia Pharmaceuticals currently has 143,833,000 shares in issue. The market capitalisation of Aurinia Pharmaceuticals is $1.12 billion. Aurinia Pharmaceuticals has a price to earnings ratio (PE ratio) of -15.74.

0UJF Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1007.87.87.800DE
4007.87.87.8387.8DE
12007.87.87.81877.8DE
26007.87.87.81107.8DE
52007.87.87.82207.8DE
156007.87.87.81087.8DE
260007.87.87.81727.8DE

0UJF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aurinia Pharmaceuticals?
El precio actual de las acciones de Aurinia Pharmaceuticals es $ 7.80
¿Cuántas acciones de Aurinia Pharmaceuticals están en circulación?
Aurinia Pharmaceuticals tiene 143,833,000 acciones en circulación
¿Cuál es la capitalización de mercado de Aurinia Pharmaceuticals?
La capitalización de mercado de Aurinia Pharmaceuticals es CAD 1.12B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals ha negociado en un rango de $ 7.80 a $ 7.80 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Aurinia Pharmaceuticals?
El ratio precio/beneficio de Aurinia Pharmaceuticals es -15.74
¿Cuál es el ratio de efectivo a ventas de Aurinia Pharmaceuticals?
El ratio de efectivo a ventas de Aurinia Pharmaceuticals es 7
¿Cuál es la moneda de reporte de Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Aurinia Pharmaceuticals?
El último ingresos anual de Aurinia Pharmaceuticals es USD 175.51M
¿Cuál es el último beneficio anual de Aurinia Pharmaceuticals?
El último beneficio anual de Aurinia Pharmaceuticals es USD -78.02M
¿Cuál es la dirección registrada de Aurinia Pharmaceuticals?
La dirección registrada de Aurinia Pharmaceuticals es 1203-4464 MARKHAM STREET, VICTORIA, BRITISH COLUMBIA, V8Z 7X8
¿Cuál es la dirección del sitio web de Aurinia Pharmaceuticals?
La dirección del sitio web de Aurinia Pharmaceuticals es www.auriniapharma.com
¿En qué sector industrial opera Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
Risk vs Reward Risk vs Reward 4 minutos hace
That would be a logical next step but I doubt they can have the necessary flight time due to power consumption? Could be wrong of course but a Tesla only get 400 miles per charge I think. 

Did you read that somewhere? Would definitely fit into ultimate stealth mode if you couldn't eve
KULR
Bull_Dolphin Bull_Dolphin 6 minutos hace
Batten down the hatches Lar, there's doozy of a storm knocking at your door.
SREZ SREZ 13 minutos hace
"As such, I expect both junior pref and common dividends to resume very soon after release."

kthomp19,
What is your updated % chance that JPS dividends are 'turned back on' (& therefore JPS presumably remain outstanding) versus being converted to either existing, or new Common?
FNMA
saskasha saskasha 16 minutos hace
Congratulations jeunke22 for explaining these evidences !
LWLG
Almosthere Almosthere 19 minutos hace
And yet you held your shares for years.

LMAO
LQMT
elks elks 24 minutos hace
Wow
TWOH
davidsson10 davidsson10 24 minutos hace
Complaining: It Ain't What It Used To Be

https://www.axios.com/2025/01/02/lawsuits-publishing-platform-lively-baldoni
Alan Brown Alan Brown 33 minutos hace
How so
ARBE
dennisdave dennisdave 33 minutos hace
Say, for instance, there was a rapid rise in the share price to say $3 or $5. If the $5m loan was paid,
here is a near fact that you did not include in your equitation and the same mistake is made at NWBO HQ. The SP will NOT improve drastically as long as NWBO plans to finance future operatio
NWBO
ElectricMountain53 ElectricMountain53 38 minutos hace
Oh yeah? Read my posts from last year and tell me again how wrong I was on everything I said! Please go ahead, I'll wait...
LWLG
ListenToMe ListenToMe 39 minutos hace
I believe this is the beginning of something BIG for ATAI. 💥
ATAI
SREZ SREZ 39 minutos hace
kthomp19,
Is there ANYTHING on your radar that Yellen/Sandra Thompson/Biden could do on a last-minute basis to really screw Commons? JPS? B4 Jan 20th?
Please really get creative. Is there anything out of Left Field that could upset the apple cart?
You also said that if Treasury
FNMA
manibiotech manibiotech 55 minutos hace
Above is from 2024 10k
True every now and then lies need to be called out in the board
NWBO
manibiotech manibiotech 56 minutos hace
SOW 6 provides for ongoing baseline costs for manufacturing at the Sawston facility and one-time milestone incentives for (a) regulatory approval of each of the three licenses required for the Sawston facility, (b) successful completion of each of the six workstreams and (c) completion of drafting k
NWBO
ListenToMe ListenToMe 1 hora hace
It does??.. PSIL is Up $2 bucks since Dec. 30th. It looks like a bottom reversal & Break-OUT imminent for PSIL 💯
PSIL
ksquared ksquared 1 hora hace
Joe Biden is using every trick in the book to wipe away the Big Stink from his tenure — but nothing is working
By Michael Goodwin Published Jan. 4, 2025, 10:16 p.m. ET
(January 20th cannot get here soon enough.)

Breaking News Alert: Joe Biden to resign so Kamala Harr
tabbycat tabbycat 1 hora hace
Exactly 
TWOH
jeunke22 jeunke22 1 hora hace
Currently the big 7 are in need of 30GW of power to realize all their datacenter and AI aspirations in the near future.
Around 0.6 GW is added ever year in the USA or one 50 Megawatt power plant every month. Currently the US is building five 1 GW Hyper Data Scale datacenters at a rough cost o
LWLG
The Danish Dude The Danish Dude 1 hora hace
Once in a while one has to repeat oneself on this board, because somehow due diligence in the short and distort scammers camp disolves itself over time.

https://iili.io/2UNjxol.md.webp

And then one can start all over reeducating the ignorant masses.

Yes,
CDMO NWBO
fuagf fuagf 2 horas hace
Just finished - The Six Triple Eight: Everything You Need to Know

"On Netflix I just finished The Killer, The Madness and Churchill at War and started on Black Doves.
Their original programming is still top notch because they can afford it."

Kerry Washing
sylvia07 sylvia07 2 horas hace
Not only synthetic shares but according to this website, dbmm has short shares.
https://www.otcshortreport.com/company/DBMM
DBMM
Seminole Red Seminole Red 2 horas hace
https://scontent-mia3-3.xx.fbcdn.net/v/t39.30808-6/472293302_905802825095374_3473832870245612767_n.jpg?_nc_cat=108&ccb=1-7&_nc_sid=0b6b33&_nc_ohc=YJtCmvz6wwMQ7kNvgHWh25c&_nc_zt=23&_nc_ht=scontent-mia3-3.xx&_nc_gid=Ae15H9ngLafLkQISdO6zu87&oh=00_AYA5xkIONTr9ECCR2EwlP9fecienD49rx9m8zqvpxYE8yA&oe=678013

Su Consulta Reciente

LSE
0UJF
Aurinia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados